Trial
NCT00583102
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Iowa
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Cytarabine
Why stopped
Slow accrual, PI left institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-05